Table 2.
Univariate Regression | Multivariate Regression | |||
---|---|---|---|---|
|
||||
OR (95% CI) |
P value* |
OR (95% CI) | P value* | |
Age (years) | ||||
≤ 46 | Reference | 0.011 | Reference | 0.427 |
> 46 | 1.59 (1.12-2.28) | 1.11 (0.72-1.71) | ||
Marital status | ||||
Married | Reference | 0.009 | Reference | 0.646 |
Unmarried | 0.52 (0.32-0.85) | 0.59 (0.33-1.05) | ||
Current use of prescribed opioid therapy for pain treatment |
||||
No | Reference | < 0.001 | Reference | < 0.001 |
Yes | 8.77 (5.02-15.31) | 7.74 (4.25-14.13) | ||
Current methadone dose (mg)a |
Reference | 0.003 | Reference | 0.027 |
1.01 (1.00-1.01) | 1.01 (1.00-1.01) | |||
Number of medical comorbiditiesb |
Reference | < 0.001 | Reference | < 0.001 |
2.34 (1.72-3.18) | 2.09 (1.45-2.99) | |||
BDI-II | ||||
Minimal/mild | Reference | < 0.001 | Reference | 0.010 |
Moderate/severe | 2.38 (1.66-3.43) | 2.25 (1.40-3.62) | ||
MOS-SF-12 | ||||
MCS | 1.00 (0.99-1.02) | 0.950 | 1.01 (0.99-1.03) | 0.330 |
PCS | 0.96 (0.93-0.98) | 0.000 | 0.97 (0.94-1.00) | 0.070 |
Abbreviations: BDI-II, Beck Depression Inventory-II; MOS-SF-12, Medical Outcomes Survey-Short Form; MCS, Mental Components Summary Score; PCS, Physical Components Summary Score, controlled for bodily pain.
OR for each 1 mg increase in methadone dose.
OR for each increasing level of comorbidity.
p < 0.05